Ozempic Shot Duration: Half-Life & Clearance Timeline

Last reviewed: May 17, 2026

Last updated: May 17, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Semaglutide injections remain detectable in your bloodstream for approximately 7 days, with a half-life ranging from 15–19 hours. This extended clearance window explains why weekly dosing schedules are effective and why dose adjustments typically occur at weekly intervals.

Understanding how long semaglutide stays in your system is medically important for several reasons: managing treatment gaps, anticipating medication interactions, and recognizing why dosing consistency matters. PlexusDx helps patients contextualize these pharmacokinetic facts within their own health profile and genetic risk factors.

Semaglutide Half-Life and Systemic Clearance Timeline

Semaglutide's half-life—the time required for your body to eliminate half of an administered dose—is approximately 15–19 hours. This relatively long half-life, compared to faster-acting insulins or GLP-1 analogs, provides a sustained pharmacologic effect with once-weekly dosing.

Within 7 days, semaglutide concentrations typically decline below therapeutic thresholds. However, plasma levels remain measurable for longer periods. Individual clearance rates vary based on age, kidney function, liver metabolism, and body composition, meaning some patients may retain slightly higher residual levels longer than others.

Pharmacokinetic Variability: Factors Affecting How Your Body Clears Semaglutide

Multiple patient factors influence how quickly or slowly your body eliminates semaglutide. Kidney and liver function, body weight, age, and concurrent medications all modulate clearance rates. This variability is one reason why a dose that works well for one patient may require adjustment for another.

Understanding your individual clearance profile supports more informed conversations with your provider about dosing schedules, missed-dose protocols, and medication interactions. Genetic predispositions in metabolic pathways may also contribute to inter-individual differences in semaglutide response and clearance.

Factor	Impact on Semaglutide Clearance
Renal Function (eGFR)	Reduced kidney function may prolong half-life; no dose adjustment required per labeling, but clinical monitoring important
Hepatic Metabolism	Liver disease may alter clearance; semaglutide undergoes proteolytic degradation, not primarily hepatic metabolism
Body Weight/BMI	Higher body weight may result in larger depot effect; clearance kinetics relatively stable across weight ranges
Age	Older adults (65+) may show slightly prolonged clearance; clinical significance typically minimal with weekly dosing
Concurrent Medications	Some oral medications may compete for GLP-1 receptor binding; timing of administration can optimize absorption

Clinical Implications of Semaglutide's Extended Duration

Because semaglutide remains active for 7 days, weekly dosing maintains relatively stable plasma concentrations when taken consistently. This sustained action supports steady appetite suppression and metabolic effects, reducing day-to-day fluctuations seen with shorter-acting agents.

If you miss a dose, you have a grace period of up to 48 hours to administer your next injection without significant loss of efficacy. Beyond 48 hours, clinical guidance typically recommends proceeding with your next scheduled dose rather than doubling up. Your provider should clarify your specific missed-dose protocol.

Genetic Predispositions and Individual Semaglutide Response Variability

While pharmacokinetic half-life is relatively consistent across patients, individual responsiveness to semaglutide varies substantially. Genetic variations in GLP-1 receptor genes (GLP1R rs6923761) and related metabolic pathways may influence how effectively your body responds to the drug, independent of clearance rate.

PlexusDx's Precision Peptide Genetic Test examines predispositions in GLP-1 signaling and appetite-regulation pathways to support a more nuanced conversation with your provider. These genetic insights, interpreted alongside pharmacokinetic data, may help tailor dosing strategies and inform whether semaglutide aligns with your metabolic profile.

How PlexusDx Supports a More Personalized Approach

PlexusDx recognizes that knowing semaglutide's half-life alone doesn't determine optimal dosing for your specific metabolism. Genetic predispositions in GLP-1 receptor pathways and related appetite-regulation genes may provide context for why some patients respond robustly to standard doses while others require optimization. This genetic insight should be interpreted with a qualified healthcare provider as one data point alongside your clinical presentation.

The Precision Peptide Genetic Test reveals predispositions in key variants including GLP1R rs6923761, which relates to GLP-1 receptor function, and FTO rs9939609, which influences appetite signaling. These markers do not predict exact semaglutide response or clearance rate, but may help you and your provider understand your baseline metabolic risk profile and optimize treatment personalization.

Understanding both pharmacokinetic half-life (how long the drug stays in your system) and your genetic predispositions in GLP-1 pathways can support a more informed conversation with your provider about dosing consistency, dose escalation, and whether compounded semaglutide formulations align with your treatment goals.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.